Induction of Labor With Misoprostol in Pregnancies With Advanced Maternal Age

dc.contributor.author Zeteroglu, Sahin
dc.contributor.author Sahin, Guler H.
dc.contributor.author Sahin, Huseyin A.
dc.date.accessioned 2025-05-10T17:07:26Z
dc.date.available 2025-05-10T17:07:26Z
dc.date.issued 2006
dc.description.abstract Objective: The objective was to compare the efficacy and complications of intravaginal misoprostol application with oxytocin infusion for induction of labor in advanced aged pregnancies with a Bishop score of <6. Study design: A hundred advanced aged (>= 35 years) pregnant patients with a Bishop score of <6 were randomized into two groups. The first group (50 patients) received 50 mu g intravaginal misoprostol four times with 4 h intervals and the second group received oxytocin infusion for induction of labor starting from 2 mIU/min and was increased every 30 min with 2 mIU/min increments up to a maximum of 40 mIU/min. The time from induction to delivery, the route of delivery, fetal outcome, and maternal complications were recorded. Statistical analyses were performed using the Mann-Whitney U, Chi-squared and t tests to determine differences between the two groups. A p value <= 0.05 was considered significant. Results: Misoprostol was superior for induction of labor in advanced aged pregnancies with Bishop score of <6, as the mean time from induction to delivery was 9.61 +/- 4.12 h and 11.46 +/- 4.86 h in the misoprostol and oxytocin groups respectively, with a significant difference between the groups (p = 0.04). The rate of vaginal delivery was higher in the misoprostol group (84.0%) than in the oxytocin group (80.0%), but the difference did not reach significance (p = 0.60). The rates of placental abruption and postpartum hemorrhage were similar in both groups and no cases of uterine rupture occurred. The 1- and 5-min mean Apgar scores were 6.98 +/- 1.17 to 9.08 +/- 0.99 and 6.88 +/- 1.81 to 9.00 +/- 1.35 in the misoprostol and oxytocin groups respectively, with no significant differences between the groups (p = 0.74, p = 0.83). No cases of asphyxia were present. The rate of admission to the neonatal intensive care unit was similar in both groups. Conclusion: Intravaginal misoprostol seems to be an alternative method to oxytocin in the induction of labor in advanced aged pregnant women with low Bishop scores, as it is efficacious, cheap, and easy to use. But large studies are necessary to clarify safety with regard to the rare complications such as uterine rupture. (C) 2005 Elsevier Ireland Ltd. All rights reserved. en_US
dc.identifier.doi 10.1016/j.ejogrb.2005.11.040
dc.identifier.issn 0301-2115
dc.identifier.issn 1872-7654
dc.identifier.scopus 2-s2.0-37849188172
dc.identifier.uri https://doi.org/10.1016/j.ejogrb.2005.11.040
dc.identifier.uri https://hdl.handle.net/20.500.14720/6768
dc.language.iso en en_US
dc.publisher Elsevier Science Bv en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Induction Of Labor en_US
dc.subject Advanced Maternal Age en_US
dc.subject Misoprostol en_US
dc.subject Oxytocin en_US
dc.title Induction of Labor With Misoprostol in Pregnancies With Advanced Maternal Age en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 6603464756
gdc.author.scopusid 7005240094
gdc.author.scopusid 35577753600
gdc.author.wosid Şahin, Hüseyin Avni/Jwo-9166-2024
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp Mustafa Kemal Univ, Fac Med, Dept Obstet & Gynecol, Antakya, Turkey; Yuzuncu Yil Univ, Fac Med, Dept Obstet & Gynecol, Van, Turkey; Yuzuncu Yil Univ, Fac Med, Dept Family Med, Van, Turkey en_US
gdc.description.endpage 144 en_US
gdc.description.issue 2 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 140 en_US
gdc.description.volume 129 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality N/A
gdc.identifier.pmid 16406221
gdc.identifier.wos WOS:000243254600007
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files